drugset / Trial / NCT07377396
A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to assess the safety of ARGX-124 in healthy adults. Another aim is to measure the amount of ARGX-124 in the blood over time to learn how it acts and moves in the body and how the immune system responds to it. Participants will remain in the study for up to approximately 23 weeks.
Timeline
- Start
- 2026-01-26
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARGX-124 | Unknown | — | — |
Indications
No indication recorded.